Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > 51 cent support

<< Previous

Bullboard Posts

Next >>

Comment by Scotty007on Nov 05, 2021 9:39am

145 Views

Post# 34091256

RE:RE:RE:51 cent support

Potentially feels like the fund that took the placement at $1.65 has been given free rein to accumulate lower - averaging down with the knowledge that announcements will not get in the way of lifting the price until they are done.
Very quiet from Willow – they used to inform shareholders a few times per month - now we are getting to the pointy end of the stick, and all is relatively quiet.
Go figure.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages